Academic literature on the topic 'COVID-19 SYNDROME'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'COVID-19 SYNDROME.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "COVID-19 SYNDROME"

1

Smykiewicz, Jolanta, Jakub Buczkowski, Marek Mirowski, and Ryszard Tomasiuk. "Post-COVID-19 syndrome and post-COVID-19 vaccination syndrome." Medical Research Journal 10, no. 1 (2025): 1–3. https://doi.org/10.5603/mrj.101813.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Galstyan, G. M. "Coagulopathy in COVID-19." PULMONOLOGIYA 30, no. 5 (2020): 645–57. http://dx.doi.org/10.18093/0869-0189-2020-30-5-645-657.

Full text
Abstract:
Hemostatic disorders play an important role in the pathogenesis and clinical manifestations of COVID-19. The purpose of the research was a detailed consideration of the pathogenesis, clinical manifestations, and methods of diagnosing and treatment of coronavirus-induced coagulopathy (CIC). At the onset of COVID-19, hypercoagulability is detected, and consumption coagulopathy and disseminated intravascular coagulation (DIC) syndrome are usually observed at later stages of the disease. In the pathogenesis of hypercoagulation in patients with COVID-19, proinflammatory cytokines, hyperfibrinogenem
APA, Harvard, Vancouver, ISO, and other styles
3

Asfandiyarova, N. S. "Post-COVID-19 syndrome." Clinical Medicine (Russian Journal) 99, no. 7-8 (2022): 429–35. http://dx.doi.org/10.30629/0023-2149-2021-99-7-8-429-435.

Full text
Abstract:
The disease caused by new coronavirus infection (COVID-19) is a global problem not only because of its wide spread occurrance, but also due to the high incidence of post-COVID syndrome. The literature review presents the results of numerous observations of patients, who undergone COVID-19. The most common symptoms are: general weakness, impaired cognitive functions, memory loss, depression, anosmia, dysgeusia, shortness of breath, cough, chest pain, abdominal pain, anorexia, nausea, vomiting, diarrhea, less often — alopecia, skin rashes, etc. The most frequent symptoms of the post-COVID syndro
APA, Harvard, Vancouver, ISO, and other styles
4

Cha, Jae Myung. "Post-COVID-19 Syndrome." Korean Journal of Medicine 97, no. 5 (2022): 284–91. http://dx.doi.org/10.3904/kjm.2022.97.5.284.

Full text
Abstract:
Although acute COVID-19 usually lasts for 12 weeks from the onset of symptoms, some patients experience variable persistent symptoms. Post-COVID-19 syndrome is defined as persistent symptoms and/or long-term complications that appear during or after COVID-19, persist for more than 12 weeks, and cannot be explained by an alternative diagnosis. The common symptoms of post-COVID-19 syndrome include general, pulmonary, hematological, cardiovascular, neuropsychiatric, renal, endocrine, gastroenterological, and dermatological symptoms. As the natural course and pathophysiology of COVID-19 are not ye
APA, Harvard, Vancouver, ISO, and other styles
5

Jaramillo-Acosta, MA Ramírez-Salgado CA Castillo Narvaez NA Rahman Md M. "Post-COVID Syndrome: Changing the Prognosis of Chronic Non-communicable Diseases." J Biomed Res Environ Sci 3, no. 4 (2022): 391–92. https://doi.org/10.37871/jbres1453.

Full text
Abstract:
Post-COVID-19 syndrome is defined as the persistence of signs or symptoms following the acute phase of COVID-19 [1], which may persist for an indeterminate period of time; or it is defined as the period of risk following the acute phase of COVID-19 [1], in which major complications may occur depending on organ injury during the first phase of COVID-19 [1-3].
APA, Harvard, Vancouver, ISO, and other styles
6

Pierce, Janet D., Qiuhua Shen, Samantha A. Cintron, and John B. Hiebert. "Post-COVID-19 Syndrome." Nursing Research 71, no. 2 (2022): 164–74. http://dx.doi.org/10.1097/nnr.0000000000000565.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Natoli, Valentino, Vincenzo Natoli, and Antonella Rosa Longo. "Post-COVID-19 Syndrome." Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 7, no. 1 (2024): 240–41. http://dx.doi.org/10.54133/ajms.v7i1.1361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kamath, Vasantha, R. Anand, Buvana Radhakrishnan, and Kushal Markanday. "Post-COVID-19 syndrome." APIK Journal of Internal Medicine 11, no. 2 (2023): 70. http://dx.doi.org/10.4103/ajim.ajim_119_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nick, Bakalis, Andreou Aikaterini, Varzelioti Niki, Michalopoulou Antigone, Albani Eleni, and Filiotis Nikolaos. "Mobbing Syndrome during COVID-19." INTERNATIONAL JOURNAL OF MEDICAL SCIENCE AND CLINICAL RESEARCH STUDIES 02, no. 06 (2022): 498–504. https://doi.org/10.5281/zenodo.6655414.

Full text
Abstract:
Introduction: Mobbing syndrome is frequently observed in health care settings. Inadequate management has a profound effect on victims since they demonstrate difficulties in defending themselves while causing them physical, psychological, social and work-related consequences. Aim: To measure the occurrence of this phenomenon among nursing staff in the midst of a covid-19 pandemic. Methodology: The Negative Acts Questionnaire- Revised (NAQ-R), an instrument designed to measure exposure to bullying in the workplace was used. It consisted of a total of 31 questions. Chrobanch alpha reliability coe
APA, Harvard, Vancouver, ISO, and other styles
10

Mihajlović, Miroslav, Bogdan Marković, Milan Marinković, Nebojša Mujović, and Tatjana Potpara. "Long COVID-19 syndrome: An overview." Medicinski podmladak 74, no. 4 (2023): 26–34. http://dx.doi.org/10.5937/mp74-47797.

Full text
Abstract:
The Long COVID-19 syndrome has emerged as global epidemic, affecting individuals after an acute infection caused by the Severe acute respiratory syndrome coronavirus 2, impacting multiple organs, including the heart. The most common symptoms encompass fatigue and shortness of breath, which could persist for months after an acute COVID-19 infection. Numerous studies have researched the pathophysiology of Long COVID-19 syndrome, suggesting that local tissue damage and hyperinflation could be employed as possible mechanisms of Long COVID-19 syndrome. Many blood biomarkers (blood urea nitrogen, D-
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "COVID-19 SYNDROME"

1

Yáñez, Jaime A., Aldo Alvarez-Risco, and Jaime Delgado-Zegarra. "Covid-19 in Peru: From supervised walks for children to the first case of Kawasaki-like syndrome." BMJ Publishing Group, 2020. http://hdl.handle.net/10757/652436.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rodriguez-Smith, Jackeline J. "Distinct Inflammatory Biomarker Patterns in COVID-19 associated MIS-C suggest Overlap between Kawasaki Disease and Macrophage Activation Syndrome." University of Cincinnati / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1617108968401826.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Estes, Andersen, and Demetrio Macariola. "A Clinical Differentiation of Multisystem Inflammatory Syndrome in Children (MIS-C) & Kawasaki Disease (KD)." Digital Commons @ East Tennessee State University, 2021. https://dc.etsu.edu/asrf/2021/presentations/27.

Full text
Abstract:
INTRODUCTION: With the emergence of the COVID 19 pandemic, a new disease, Multisystem Inflammatory Syndrome in Children (MIS-C), had evolved. Increasing number of children are being reported to have MIS-C in the U.S. & worldwide. In the U.S. there are currently 2617 MISC cases reported. MIS-C & Kawasaki Disease (KD), have almost the same presentation, making clinical differentiation difficult. This study aims at differentiating KD & MIS-C which could assist clinicians to determine which one they could be dealing with in their practices. METHODS: Clinical features & laboratory values were colle
APA, Harvard, Vancouver, ISO, and other styles
4

Phan, Ngoc Minh Hien. "Perusing peripatetic pathogenic viruses: Hepatitis B virus and severe acute respiratory syndrome coronavirus 2." Thesis, Queensland University of Technology, 2021. https://eprints.qut.edu.au/226107/1/Ngoc%20Minh%20Hien_Phan_Thesis.pdf.

Full text
Abstract:
This project characterised the genetic diversity of hepatitis B virus (HBV) and SARS-CoV-2, which reflects viral evolution, and drives transmission, viral pathogenesis, and clinical outcomes. Genomes and coding genes of these viruses were analysed using next-generation sequencing, bioinformatic tools and publicly available viral sequences. HBV nucleotide diversity was identified amongst HBV sequences from Australian and non-Australian blood donors. In addition, the frequency of HBV mutants circulating in Southeast Asia, Australia and New Zealand was identified. Europe and East Asia were shown
APA, Harvard, Vancouver, ISO, and other styles
5

Vandersteen, Clair. "COVID long olfactif et maladie d'Alzheimer : mécanismes physiopathologiques partagés, défis diagnostiques et nouvelles approches thérapeutiques." Electronic Thesis or Diss., Université Côte d'Azur, 2024. https://theses.hal.science/tel-05000086.

Full text
Abstract:
Cette thèse a étudié les connexions potentielles entre le COVID long (CL) et la maladie d'Alzheimer (MA) étant donné les facteurs de risque et processus physiopathologiques partagés existants entre ces deux pathologies. Nous nous sommes concentrés sur les patients atteints de Dysosmies post COVID-19 persistantes (DPCP) s'intégrant donc dans un CL olfactif. Les études radiologiques et neurocognitives soutiennent des modifications cérébrales communes identifiable dans le CL et la MA, notamment l'hypométabolisme et les changements structurels dans les zones liées à l'olfaction et à la mémoire. Ce
APA, Harvard, Vancouver, ISO, and other styles
6

Brier, Lucile. "Conception d'une stratégie de découverte de composés antiviraux contre les coronavirus : du criblage à l'optimisation d'inhibiteurs de la protéase 3CL du SARS-CoV-2." Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS031.

Full text
Abstract:
Les coronavirus sont des virus à ARN provoquant des maladies respiratoires, entériques, hépatiques et neurologiques de gravité variable chez différentes espèces, dont l'Homme. Parmi eux, sept peuvent infecter l'Homme. Les souches HCoV-OC43, HCoV-NL63, HCoV-229E et HCoV-HKU1 entraînent des infections légères des voies respiratoires. Le SARS-CoV, le MERS-CoV et le SARS-CoV-2, potentiellement mortels, ont quant à eux été à l'origine de pandémies. Aujourd'hui, le SARS-CoV-2 circule toujours mais la stratégie vaccinale a permis de réduire significativement les risques d'hospitalisation et de décès.
APA, Harvard, Vancouver, ISO, and other styles
7

Habas, Khaled S. A., C. Nganwuchu, F. Shahzad, et al. "Resolution of coronavirus disease 2019 (COVID-19)." 2007. http://hdl.handle.net/10454/17989.

Full text
Abstract:
Yes<br>Introduction. Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on supportive therapy and treatment to prevent respiratory failure. The effective option of antiviral therapy and vaccination are currently under evaluation and development. Areas covered. A literature search was performed using PubMed between December 1, 2019–June 23, 2020. This review highlights the current state of knowledge on the viral replication
APA, Harvard, Vancouver, ISO, and other styles
8

Habas, Khaled S. A., Chinyere C. Nganwuchu, F. Shahzad, et al. "Resolution of coronavirus disease 2019 (COVID-19)." 2020. http://hdl.handle.net/10454/17989.

Full text
Abstract:
Yes<br>Introduction. Coronavirus disease 2019 (COVID-19) was first detected in China in December, 2019, and declared as a pandemic by the World Health Organization (WHO) on March 11, 2020. The current management of COVID-19 is based generally on supportive therapy and treatment to prevent respiratory failure. The effective option of antiviral therapy and vaccination are currently under evaluation and development. Areas covered. A literature search was performed using PubMed between December 1, 2019–June 23, 2020. This review highlights the current state of knowledge on the viral replication
APA, Harvard, Vancouver, ISO, and other styles
9

Матюхіна, Олена Юріївна. "Особливості психологічних станів людини в умовах COVID 19". Магістерська робота, 2021. https://dspace.znu.edu.ua/jspui/handle/12345/6444.

Full text
Abstract:
Матюхіна О. Ю. Особливості психологічних станів людини в умовах COVID 19 : кваліфікаційна робота магістра спеціальності 053 «Психологія» / наук. керівник А. П. Поплавська. Запоріжжя : ЗНУ, 2021. 80 с.<br>UA : Робота викладена на 80 сторінок, рисунки, 7 таблиць, 3 додатка. Перелік посилань включає 80 джерел. Об’єкт дослідження: психологічні стани, викликані Covid-19. Пандемія коронавірусу, яка охопила світ у 2020 році, докорінно змінила життя українців. Причому зміни торкнулися і роботи та доходів, і навіть таких речей, як спосіб життя, дозвілля і спілкування. Безсумнівно, найбільший вплив ко
APA, Harvard, Vancouver, ISO, and other styles
10

Oliveira, André Alexandre Campos. "Burnout nos enfermeiros e médicos durante a pandemia COVID-19." Master's thesis, 2021. http://hdl.handle.net/10071/23831.

Full text
Abstract:
Através de dados quantitativos este estudo aborda a prevalência do burnout nos enfermeiros e médicos durante a pandemia COVID-19 em Portugal, que se intensificou com as medidas de combate à pandemia. A amostra foi constituída por 795 enfermeiros e 151 médicos e os dados foram recolhidos através de um questionário eletrónico. Os níveis de burnout foram estimados pelo Maslach Burnout Inventory – HSS, e 77% dos participantes apresentaram níveis elevados na exaustão emocional, 44,4% níveis elevados de despersonalização e 58,5% níveis baixos de realização pessoal. 31,3% dos profissionais apr
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "COVID-19 SYNDROME"

1

Shoenfeld, Yehuda, and Arad Dotan. Effects and Post-COVID 19 Syndrome on Autoimmunity. Elsevier Science & Technology Books, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shoenfeld, Yehuda, and Arad Dotan. Effects and Post-COVID 19 Syndrome on Autoimmunity. Elsevier Science & Technology, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

COVID-19 and Hyper Inflammation Syndrome: Different Presentation and Management. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-83250-305-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Narayanan, Jwala, and Anjana Xavier. Neuropsychological Consequences of COVID-19: Life after Stroke and Balints Syndrome. Taylor & Francis Group, 2024.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shisō to shite no "shingata korona uirusu-ka": Severe acute respiratory syndrome, coronavirus 2, SARS-CoV-2. Kawade Shobō Shinsha, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

COVID-19 Severity in Obese Patients : Potential Mechanisms and Molecular Targets for Clinical Intervention: SARS-CoV-2 COVID-19 Obesity Inflammation Coronavirus Metabolic Syndrome. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Qi, Wensheng, Zhixu Yang, Hao Li, Luqi Huang, and Qing Miao. Covid-19 from Traditional Chinese Medicine Perspective: Severe Clinical Cases in the Context of Syndrome Differentiation. World Scientific Publishing Co Pte Ltd, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Molecular Diagnostics and Biological Safety 2021. COVID-19: Epidemiology, Diagnosis and Prophylaxis: Conference Abstracts. Central Research Institute for Epidemiology, 2021. http://dx.doi.org/10.36233/978-5-6045286-2-4.

Full text
Abstract:
The pandemic of the new coronavirus infection has spread to more than 200 countries. To date, over 130 million people have been affected and over 2.8 million have died. COVID-19 infection has a number of specific epidemiological and clinical features. In severe cases of the disease, acute respiratory distress syndrome develops, which is often fatal. The SARS-CoV-2 virus is susceptible to mutations, which alarms the scientific community all over the world. Therefore, scientific research in the field of COVID-19, the search for new diagnostic tools, methods for nonspecific and specific preventio
APA, Harvard, Vancouver, ISO, and other styles
9

Al-Anazi, KA, WK Al-Anazi, and AM Al-Jasser. Update on COVID-19 Infections and the Promising Role of Mesenchymal Stem Cell Therapies in their Management. Heighten Science Publications Inc., 2020. http://dx.doi.org/10.29328/ebook1002.

Full text
Abstract:
The pandemic of COVID-19 has adversely affected almost every aspect of our lives but the world health and economic sectors suffer most of the repercussions of this disease. The search for a cure for this rapidly spreading virus which is causing massive life losses around the globe requires clear understanding of the immunopathogenesis of this virus as well as the mechanisms of actions of the various therapeutic modalities that are employed in the treatment of this life-threatening viral infection. Mesenchymal stem cells have antimicrobials effects in addition to their anti-inflammatory and imm
APA, Harvard, Vancouver, ISO, and other styles
10

Webster, Kerry. Traditional Chinese Medicine in the Treatment of Post COVID-19 Syndrome: Zhong Yi Zhen Zhi Xin Guan Chang Qi Bing Zheng. World Scientific Publishing Co Pte Ltd, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "COVID-19 SYNDROME"

1

Narayanan, Jwala, Anjana Xavier, Jonathan Evans, Narinder Kapur, and Barbara Wilson. "Balint's Syndrome." In Neuropsychological Consequences of COVID-19. Routledge, 2024. http://dx.doi.org/10.4324/9781003203940-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Klimov, Vladimir V. "Allergies in COVID-19 and Post-COVID Syndrome." In Textbook of Allergen Tolerance. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04309-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

van de Veerdonk, Frank Leo. "COVID-19 Pneumonia and Cytokine Storm Syndrome." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-59815-9_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Li, Leon Wai, Wing Tung Percy Ho, and Pui Yu Chesney Wong. "Appropriate Care and Post-COVID-19 Syndrome." In Gaps and Actions in Health Improvement from Hong Kong and Beyond. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-4491-0_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Midha, Vandana, Jyoti Jindal, Vandana Kaushal, R. C. Sobti, and Rama Gupta. "COVID-19: Clinical Spectrum—It’s Multiorgan Syndrome." In Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-5105-2_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Malbrain, Manu L. N. G., Serene Ho, Prashant Nasa, and Adrian Wong. "Fluid Management in COVID-19." In Rational Use of Intravenous Fluids in Critically Ill Patients. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-42205-8_26.

Full text
Abstract:
AbstractUpon initial presentation, most COVID-19 patients are in a stable haemodynamic state and typically do not require intravenous (IV) fluid resuscitation. The virus primarily affects the lungs, thus the initial focus is on providing oxygen and respiratory support to the patient. Although there is limited direct research on IV fluid management for COVID-19 patients, data from observational studies suggest that patients with COVID-19-related acute respiratory distress syndrome (ARDS) exhibit higher levels of extravascular lung water and require longer periods of mechanical ventilation the m
APA, Harvard, Vancouver, ISO, and other styles
7

Blum, Dinur, Stacy L. Smith, and Adam G. Sanford. "Toxic Wild West Syndrome." In COVID-19. Routledge, 2020. http://dx.doi.org/10.4324/9781003142065-13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jara, Luis J., Caroline I. Gutierrez-Melgarejo, Irvin Ordoñez-González, et al. "COVID-19." In Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. Elsevier, 2023. http://dx.doi.org/10.1016/b978-0-443-18566-3.00033-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lidiia, Soprun, Natalia Gavrilova, Varvara A. Ryabkova, Lukashenko Maria, and Kamaeva Evelina. "The post-COVID syndrome." In Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. Elsevier, 2023. http://dx.doi.org/10.1016/b978-0-443-18566-3.00027-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Emeršič, Nina, and Tadej Avčin. "Multisystem inflammatory syndrome in children." In Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination. Elsevier, 2023. http://dx.doi.org/10.1016/b978-0-443-18566-3.00015-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "COVID-19 SYNDROME"

1

Bontsevich, Roman, Yana Vovk, and Liliya Solovyova. "COVID-19: treatment of early chronic COVID syndrome." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa3674.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Russo Macchi, María Verónica, Vanessa Félix Nascimento Coelho, Thais de Campos Ferreira Pinto, Lucas Eduardo Pedri, and Flavia Regina Andrade. "POST-COVID-19 CHRONIC FATIGUE SYNDROME." In Congresso Brasileiro de Reumatologia 2020. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2020.17076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aamir, N. "Post COVID-19 Guillain-Barré Syndrome." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2486.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Coppetti, Liara Eickhoff, Lana Caroline Palaver Dall’Ago Dall’Ago, and Andressa Wierzbicki. "Guillain-Barre related to Covid-19." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.525.

Full text
Abstract:
Background: COVID-19 is a disease that affects the nervous system as proven by the presence of symptoms such as headache, nausea, dizziness, myalgia, anosmia and ageusia - and can cause numerous neurological complications. These complications include Guillain-Barré Syndrome, an autoimmune polyneuropathy usually caused by a previous infectious process. Its main clinical manifestation is asthenia in the limbs, in an ascending form. Objectives: Review studies that suggest relation between COVID-19 infection and Guillain-Barré Syndrome. Methods: A systematic review was carried out in April of 2021
APA, Harvard, Vancouver, ISO, and other styles
5

Friha, Mariem, Hajer Racil, Mariem Chaabane, et al. "Tabacco smoking and post COVID-19 syndrome." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa4565.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fesu, Dorottya, Lorinc Polivka, Eniko Barczi, et al. "Long-COVID syndrome and interstitial lung disease following COVID-19." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa3923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Logvinenko, Irina. "EXPERIENCE OF FOLLOW-UP MONITORING OF COVID-19 CONVALESCENTS (LONG COVID SYNDROME)." In Proceedings of the Second Eurasian Conference. “ZANGAZURDA” PUBLISHING HOUSE BAKU, AZERBAIJAN, 2021. http://dx.doi.org/10.36719/2663-4619/2021/1.

Full text
Abstract:
Abstract: Various clinical scenarios of the course of the post-COVID syndrome in the period of convalescence were studied. The frequency and volume of studies in combined pathology in patients who have undergone COVID-19 are considered. The controlled indicators of the medical state within the framework of follow-up monitoring and the minimum frequency of follow-up visits were clarified. Key words: New coronavirus infection, convalescents, the long COVID syndrome, follow-up monitoring
APA, Harvard, Vancouver, ISO, and other styles
8

Corrêa, Maria Cecilia Dias, Victória Dornelas Paz Carvalho, Kleiça Tawana Cruz Oliveira, et al. "CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AFTER VACCINATION AGAINST COVID-19." In XXXIX Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2022. http://dx.doi.org/10.47660/cbr.2022.2024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tran, D. H., Z. Bilgrami, C. Kwon, et al. "Guillain-Barre Syndrome Secondary to COVID-19 Infection." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Espinoza Barrera, D. E., J. Fesen, and J. L. Denson. "Evans Syndrome in a Patient with COVID-19." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1666.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "COVID-19 SYNDROME"

1

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. COVID-19 Küresel Salgın Değerlendirme Raporu. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.118.

Full text
Abstract:
"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and Internati- onal Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short t
APA, Harvard, Vancouver, ISO, and other styles
2

F, Verdugo-Paiva, Izcovich A, Ragusa M, and Rada G. Lopinavir/ritonavir for COVID-19: A living systematic review. Epistemonikos Interactive Evidence Synthesis, 2024. http://dx.doi.org/10.30846/ies.4f3c02f030.v1.

Full text
Abstract:
Objective Provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods We conducted searches in the special L.OVE (Living OVerview of Evidence) platform for COVID-19, a system that performs regular searches in PubMed, Embase, CENTRAL, and other 33 sources. We searched for randomized trials and non-randomized studies evaluating the effect of lopinavir/ritonavir versus placebo or no treatment in patients with COVID-19. Two reviewers independently evaluated potentially eligible studies, accordin
APA, Harvard, Vancouver, ISO, and other styles
3

Santos Sales, Déborah, Mariana Beiral Hammerle, Rayanne da Silva Souza, et al. Long Covid-19 Syndrome: the Prevalence of Neuropsychiatric Symptoms in Patients with Olfactory Disorders. Progress in Neurobiology, 2023. http://dx.doi.org/10.60124/j.pneuro.2023.30.01.

Full text
Abstract:
Background: Among the frequently reported symptoms in long-term COVID-19 syndrome, we can highlight olfactory disorders depression, anxiety, and fatigue. OD can affect people's physical and mental health and can lead to neuropsychiatric symptoms. Objective: Determine the prevalence of symptoms of depression, anxiety, and fatigue in patients with olfactory disorders induced by long-term COVID-19; and investigate this impact on the quality of life. Methods: The study included 30 patients with confirmed long-term COVID-19, with persistent complaints of olfactory dysfunction. OD was evaluated by t
APA, Harvard, Vancouver, ISO, and other styles
4

Galán-Arroyo, Carmen, Javier de los Ríos-Calonge, Daniela Peñaloza González, Antonio Castillo-Paredes, and Jorge Rojo-Ramos. Quality of Life of Older Adults with Post-Acute COVID-19 Syndrome: a Scoping Review Protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0057.

Full text
Abstract:
Review question / Objective: “How does post-acute COVID-19 syndrome affect health-related quality of life (physical-mental-social functioning) in older adults?”. P – People of older adulthood. C – Quality of Life. C – Post-Acute COVID-19 Syndrome. Eligibility criteria: Studies will be assessed for inclusion in the review according to the following criteria: Study Design: We will only include studies that investigate the impact of Post-Acute COVID-19 Syndrome on Quality of Life in older adults. This includes primary research (peer-reviewed research articles), evidence synthesis (narrative revie
APA, Harvard, Vancouver, ISO, and other styles
5

Şeker, Muzaffer, Ali Özer, Zekeriya Tosun, Cem Korkut, and Mürsel Doğrul, eds. The Assessment Report on COVID-19 Global Outbreak. Türkiye Bilimler Akademisi, 2020. http://dx.doi.org/10.53478/tuba.2020.119.

Full text
Abstract:
"In late December 2019, a large number of patients with unknown causes of pneumonia were reported by press from a seafood market in Wuhan, Hubei province, China. This coronavirus was originally named the 2019 new coronavirus (2019-nCoV) by the World Health Organization (WHO) on January 12, 2020. The Coronavirus Working Group (CSG) of the WHO and International Committee proposed to call the new virus SARS-CoV-2 on February 11, 2020. As a result of the samples taken from the patient, the whole genome sequence of the SARS-CoV-2 was isolated on January 7, 2020, by Chinese scientists in a short tim
APA, Harvard, Vancouver, ISO, and other styles
6

Nunes, Isadora, Katia Sá, Mônica Rios, Yossi Zana, and Abrahão Baptista. Non-invasive Brain Stimulation in the Management of COVID-19: Protocol for a Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0033.

Full text
Abstract:
Review question / Objective: What is the efficacy or effectiveness of NIBS techniques, specifically repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcutaneous auricular vagus nerve stimulation (taVNS), percutaneous auricular vagus nerve stimulation (paVNS), and neck vagus nerve stimulation (nVNS), in the control of outcomes associated with COVID-19 in the acute or post-COVID persistent syndrome? Eligibility criteria: Included clinical studies assessed participants with acute or persist
APA, Harvard, Vancouver, ISO, and other styles
7

Rojo-Ramos, Jorge, Javier de los Ríos-Calonge, Daniela Peñaloza González, Antonio Castillo-Paredes, and Carmen Galán-Arroyo. Quality of Life of Children and Adolescents with Post-Acute COVID-19 Syndrome: a Scoping Review Protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0049.

Full text
Abstract:
Review question / Objective: The aim is to conduct a scoping protocol to identify and map how post-acute COVID-19 syndrome affect the quality of life (physical-mental-social functioning) of children and adolescents. Eligibility criteria: Studies will be assessed for inclusion in the review according to the following criteria: Study Design: We will only include studies that investigate the impact of Post-Acute COVID-19 Syndrome on Quality of Life in children and adolescents. This includes primary research (peer-reviewed research articles), evidence synthesis (narrative reviews, systematic revie
APA, Harvard, Vancouver, ISO, and other styles
8

Jara Donoso, Angel, Nathacha Garces, Claudio Farías-Valenzuela, Paloma Ferrero-Hernandez, Gerson Ferrari, and Antonio Castillo-Paredes. Effects of aerobic training on respiratory capacity in patients with Post-Covid 19 syndrome. A systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.6.0093.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Coronel-Monje, Katiusca, Mayron Antonio Candia-Puma, Juan Jeferson Vilca-Alosilla, et al. A Systematic Review of Peruvian Contributions to Scientific Publications on Experimental Research Against COVID-19. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.4.0080.

Full text
Abstract:
Review question / Objective: The objective of this research work is to evaluate the generation capacity of experimental research carried out in Peru, which will help in making future decisions, both to establish future studies, to elucidate the lack of studies in certain areas, as well as to determine the country's roadmap in a current and future state of emergency. Condition being studied: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported in December 2019 in Wuhan, China, and has spread worldwide becoming a pandemic
APA, Harvard, Vancouver, ISO, and other styles
10

F, Verdugo-Paiva, Izcovich A, Ragusa M, and Rada G. Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol. Epistemonikos Interactive Evidence Synthesis, 2024. http://dx.doi.org/10.30846/ies.4f3c02f030.

Full text
Abstract:
Objective To assess the efficacy and safety of lopinavir/ritonavir for the treatment of patients with COVID-19. Design This is the protocol of a living systematic review. Data sources We will conduct searches in the [https://app.iloveevidence.com/loves/5e6fdb9669c00e4ac072701d](L.OVE platform for COVID-19), a system that maps PICO questions to a repository maintained through regular searches in electronic databases, preprint servers, trial registries and other resources relevant to COVID-19. No date or language restrictions will be applied. Eligibility criteria for selecting studies and method
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!